2 Beaten-Down Stocks With 80% to 113% Upside, According to Wall Street

It isn't easy to know what will transpire in the stock market in the next 12 months. The COVID-19 pandemic isn't over, and the world faces uncertainty regarding various economic and geopolitical issues. However, some companies have what it takes to perform exceptionally well in the next year, at least according to Wall Street.

Let's look at two stocks whose average price targets by Wall Street analysts imply substantial upsides over their current levels: DexCom (NASDAQ: DXCM) and Tandem Diabetes Care (NASDAQ: TNDM). Is the Street right about these two diabetes-focused companies?

Source Fool.com